People with macular degeneration and other forms of central vision loss can see details like text and faces with this device.

A clinical trial is investigating whether a stem cell-derived patch can replace disease-damaged cells and restore vision. Age-related macular degeneration is a steadily worsening eye disease and the ...

Outlook Therapeutics shares slid after the company's macular degeneration drug was once again rejected by the Food and Drug Administration. The stock dropped 71% to 45 cents a share in after-hours ...

The AMD market is expected to grow at a CAGR of 10.2% over the course of the forecast period (2024–34), reaching $20.5bn ...

In July 2025, Novartis Pharmaceuticals conducted a study is to assess the effect of Iptacopan to prevent conversion of early ...

Diabetic macular edema (DME) is a complication of diabetes that occurs when fluid builds up in the macula, the part of the retina responsible for central vision. This can lead to blurred or double ...

The eye condition, which can induce the loss of central vision, could see effective treatment options pending FDA approval. Macular telangiectasia (MacTel) has long gone without a consensus treatment ...

People with proliferative diabetic retinopathy may develop another eye condition called macular edema. The macula is the part of the retina that processes the images in the center of your vision ...

Many of us are painfully aware of our body's increasing number of shortcomings as we get older. Sagging skin, hearing loss, receding hairlines and tending to use the bathroom more frequently than we ...

The macula is the center part of your retina. It gives you your central vision, what you see right in front of you. When the macula is damaged, you can still see around the edges of your vision, ...

The age-related macular degeneration (AMD) market in the seven major markets (7MM: USA, France, Germany, Italy, Spain, the UK ...